Arca
Skip to content
Tools
Tools

Warning Letter to Vitang Technology LLC

Medical Devices. See Vitang Technology's company page or this site's inspections.

On Jul 23, 2024, FDA's CDRH sent Vitang Technology LLC a warning letter.

  • Letter date: Jul 23, 2024
  • Issued by: CDRH
  • Closeout: โ€”

The Letter

As posted on FDA.gov โ†—; cited 21 CFR sections link to their page.

Dr. Mr. Jiang,

The Food and Drug Administration has completed an evaluation of your corrective actions in response to Warning Letter #653455 dated 6/12/2023. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely, /S/ Jessica Mu Compliance Branch Director Office of Medical Devices and Radiological Health Operations Division 3/West

The Firm's Other Letters

Same company or the same FDA site, newest first

Record

Recipient
Ronald Jiang
FDA site ID (FEI)
3015549533
Cited
โ€”

Tags are assigned by Arca from the letter's text. A closeout letter means FDA found the firm's corrections adequate; no closeout does not mean the issues are unresolved. FDA warning letters

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.